Academic literature on the topic 'Therapeutic use of poppies'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Therapeutic use of poppies.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Therapeutic use of poppies"

1

Nadler, S. F., M. A. Prybicien, D. Sicher, G. A. Malanga, M. DePrince, and J. E. Bowen. "THERAPEUTIC MODALITY USE." Medicine & Science in Sports & Exercise 33, no. 5 (May 2001): S90. http://dx.doi.org/10.1097/00005768-200105001-00519.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dvorak, J. "Therapeutic use exemption." British Journal of Sports Medicine 40, Supplement 1 (July 1, 2006): i40—i42. http://dx.doi.org/10.1136/bjsm.2006.027490.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wall, Jenny, Sally Davis, and Samantha Ridgway. "Cannabis: its therapeutic use." Nursing Standard 16, no. 10 (November 21, 2001): 39–44. http://dx.doi.org/10.7748/ns2001.11.16.10.39.c3123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Whall, Ann L. "THERAPEUTIC USE OF SELF." Journal of Gerontological Nursing 14, no. 2 (February 1, 1988): 38–39. http://dx.doi.org/10.3928/0098-9134-19880201-09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Winblad, Bengt, Mario Fioravanti, Tomas Dolezal, Inara Logina, Ivan Gospodinov Milanov, Dinu Cristian Popescu, and Alina Solomon. "Therapeutic Use of Nicergoline." Clinical Drug Investigation 28, no. 9 (2008): 533–52. http://dx.doi.org/10.2165/00044011-200828090-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hogaboam, Cory, Cynthia Bone-Larson, Akihiro Matsukawa, Matthew Steinhauser, Kate Blease, Nicholas Lukacs, and Steven Kunkel. "Therapeutic Use of Chemokines." Current Pharmaceutical Design 6, no. 6 (April 1, 2000): 651–63. http://dx.doi.org/10.2174/1381612003400605.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rodriguez, Mariano, Juan Munoz-Castaneda, and Yolanda Almaden. "Therapeutic Use of Calcitriol." Current Vascular Pharmacology 12, no. 2 (April 2014): 294–99. http://dx.doi.org/10.2174/15701611113119990021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Grotenhermen, Franjo. "Therapeutic use of cannabis." Lancet 351, no. 9104 (March 1998): 758–59. http://dx.doi.org/10.1016/s0140-6736(05)78538-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Soothill, James, Catherine Hawkins, Erik Änggår, and David Harper. "Therapeutic use of bacteriophages." Lancet Infectious Diseases 4, no. 9 (September 2004): 544–45. http://dx.doi.org/10.1016/s1473-3099(04)01127-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Stiehm, E. Richard, Jordan S. Orange, Mark Ballow, and Heather Lehman. "Therapeutic Use of Immunoglobulins." Advances in Pediatrics 57, no. 1 (January 2010): 185–218. http://dx.doi.org/10.1016/j.yapd.2010.08.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Therapeutic use of poppies"

1

Tibi, Selma. "The medicinal use of opium by Baghdad physicians in the ninth century." Thesis, University of Oxford, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.270570.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ramez-Baydoun, Lubna Lulu. "Novel chelating agents for therapeutic use." Thesis, King's College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.406043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Betz, Jennifer. "The Use of Improvisation in Therapeutic Practices." Kent State University Honors College / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ksuhonors1557312650223249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Xiang, Hong. "Effects of myo-inositol and, or triiodothyronine (T₃) treatment on cardiac dysfunction and elevated myocardial lipid levels in STZ-diabetic rats." Thesis, University of British Columbia, 1987. http://hdl.handle.net/2429/26675.

Full text
Abstract:
A number of experimental studies have implied a link between diabetes-induced lipid accumulation in the myocardium and the development of cardiomyopathy. Since diabetics excrete large amounts of myo-inositol which is a lipotropic agent, this study was undertaken to investigate the effects of myo-inositol on the elevated myocardial lipid levels and the depressed cardiac performance of diabetic rats. Diabetes was induced in female Wistar rats (190-215 g) with streptozotocin (STZ) (55 mg/kg, i.v.). Three days after diabetes induction, myo-inositol was administered in the drinking water (2.5 g/kg/day) for a 8 week period. Untreated diabetics exhibited a loss of body weight, hyperglycemia, hypoinsulinemia and hypothyroidism. These effects were not altered after myo-inositol treatment. STZ-diabetes also produced a significant elevation of plasma and myocardial triacylglycerol, cholesterol and phospholipid. Myo-inositol treatment decreased these lipid levels. In addition, hearts from diabetic animals had a decreased ability to develop left ventricular developed pressure (LVDP) and both the rate of pressure rise (+dP/dt) and the rate of pressure decline (-dP/dt) were also reduced. Hearts from myo-inositol-treated diabetic animals showed a partial but definite improvement of cardiac function. As diabetes-induced hypothyroidism was not altered after myo-inositol supplementation, a combination treatment of both myo-inositol (2.5 g/kg/day, p.o. daily) and T₃ (30 ug/kg/day, s.c. daily) was then undertaken to determine whether heart function of diabetic rats could be further improved. STZ-diabetic rats were characterized by a loss of body weight, hyperglycemia and hypoinsulinemia; none of which were altered by either T₃ or myo-inositol plusT₃ treatment. T₃ treatment normalized the thyroid state of diabetic animals as shown by Tahiliani and McNeill (1984). However, plasma and myocardial triacylglycerol, cholesterol and phospholipid levels of diabetic rats either remained elevated or were further increased with T₃ or myo-inositol plus T₃ treatment. In addition, T₃ treatment alone did not prevent cardiac dysfunction in diabetic rats. There was, however, some improvement in heart function in the groups treated with both myo-inositol and T₃, but the improvement was not as pronounced as with myo-inositol treatment alone.
Pharmaceutical Sciences, Faculty of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
5

Alder, Louise B. A. "Immunoregulatory properties of polyclonal immunoglobulin for therapeutic use." Thesis, University of Newcastle Upon Tyne, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.361937.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lloyd, Jonathan. "The therapeutic use of metaphor : a heuristic study." Thesis, University of Manchester, 2015. https://www.research.manchester.ac.uk/portal/en/theses/the-therapeutic-use-of-metaphor-a-heuristic-study(a020949f-3653-4812-af1d-ccbf49e53f98).html.

Full text
Abstract:
Background: This research was designed to explore the experience and understanding of counsellors' and psychotherapists' engagement with metaphors in the therapeutic process. The aim is to reflect on the experience of therapists involved in therapeutic metaphors from differing perspectives. Methodology: In a heuristic study a group of seven therapists (counsellors and psychotherapists) shared their use of metaphors in their therapy practice. Data were collected through an informal conversational interview that supported the participants to share their experiences in a natural dialogue. Findings: The experience of using metaphor in therapy appears to involve a multi-faceted web of generation, construction and development between the therapist and client. Various levels of depth of metaphor in therapy were identified along with links to transferential and cultural issues. Metaphors of hope also appear to be potentially important. Discussion: The findings suggest that the use of metaphors in therapy is pervasive. Metaphors that reflect an empathic connection and encounter between therapist and client were identified. Dualistic thinking around the origination of metaphors in therapy is challenged and the concept of co-creation and the mutual development of moving metaphors is discussed. Environmental and cultural influences are considered alongside transferential aspects. Conclusion: It appears that the use of metaphor in therapy is pervasive and offers an opportunity for therapeutic change. The consideration of the construction of metaphors and their mutual development may be useful for therapists to consider. This research highlights the need for more investigation with regard to client perspectives, the environmental impacts on metaphors in therapy and who the therapist and client stand for metaphorically for each other.
APA, Harvard, Vancouver, ISO, and other styles
7

Ngwa, Conelius. "Use of peptide nucleic acids as therapeutic agents." Thesis, Aston University, 2014. http://publications.aston.ac.uk/24385/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Marnewick, Jeanine Lucasta. "Cancer modulating properties of unique South African herbal teas (rooibos and honeybush) in short term in vitro and in vivo carcinogenesis assays." Thesis, Stellenbosch : Stellenbosch University, 2004. http://hdl.handle.net/10019.1/21888.

Full text
Abstract:
Dissertation (PhD)--University of Stellenbosch, 2004.
ENGLISH ABSTRACT: This thesis provides the first scientific evidence on the cancer modulating properties of two unique South African herbal teas, rooibos (Aspalathus Iinearis) and honeybush (Cyclopia intermedia) utilizing in vitro as well as in vivo carcinogenesis assays by: • Demonstrating the in vitro antimutagenic activity of aqueous extracts of the herbal teas against the metabolic activated mutagens, 2-acetylaminofluorene (2- AAF) and the mycotoxin, aflatoxin B1 (AFB,) as well as, to a certain extent, against the direct acting mutagen, hydrogen peroxide, utilizing the Salmonella typhimurium mutagenicity assay. • Increasing the activity of hepatic drug metabolizing enzymes, glutathione Stransferase alpha and UPD-glucuronosyl transferase, and reduced the oxidative stress by stabilizing the level of reduced glutathione (GSH) resulting in an increased hepatic reduced to oxidized glutathione ratio (GSG:GSSG). No toxic effects were noticed in rats consuming the herbal teas for 10 weeks as their sole source of drinking fluid. • Demonstrating the ex vivo modulation of 2-AAF- and AFB1-induced mutagenesis by sub- cellular hepatic fractions of rats consuming the herbal teas in the Salmonella mutagenicity assay. Hepatic cytosolic fractions protected against mutagenesis of both mutagens, while the microsomal fractions exhibited a reduced capacity to metabolize AFB1 to its active mutagenic metabolite. • Providing evidence for the in vivo modulation of tumour promotion using the liver as well as the two-stage skin carcinogenesis animal models. The unprocessed herbal teas arrested proliferation of the placental form of glutathione-Stransferase (GSTP+) altered cells as well as reduced the total number of enzyme altered foci in the liver of rats. Topical application of polyphenolic fractions of the various herbal teas prior to 12-0-tetra-decanoylphorbol-13-acetate (TPA) tumour promotion, reduced tumour formation in mouse skin initiated with 7,12-dimethylbenz[ ajanthracene (DMBA). The protective effect was illustrated by a decreased tumour incidence, a reduction in tumour volume as well as a delayed onset of tumour development. The f1avanol/proanthocyanidin content of the fractions could playa major role in the protection against skin tumour promotion. • Proposing possible mechanisms whereby rooibos and honeybush herbal teas could exert their cancer modulating properties with respect to in vitro and ex vivo antimutagenicity, in vivo oxidative status and reduced tumour promotion. • Providing evidence that the herbal teas mimic the cancer modulating properties of green and black teas although differences exist, presumably due to differences in the polyphenolic constituents. • Suggesting that rooibos and honeybush herbal teas may play an important role as chemopreventive agents in the modulation of cancer.
AFRIKAANSE OPSOMMING: Hierdie tesis bevat die eerste ondersoek na die effek van waterige en polifenoliese ekstrakte van rooibos (Aspalathus Iinearis) en heuningbos (Cyclopia intermedia) op verskeie aspekte van kankerontwikkeling. Die twee kruietees is uniek aan Suid-Afrika en kan 'n belangrike rol speel in die voorkoming van kanker. Verskillende in vitro so wei as in vivo studies het die volgende getoon: • Antimutageniese aktiwiteite teen die metabolies-geaktiveerde mutagene, 2- asetielaminofluoreen (2-AAF) en die mikotoksien, aflatoksien B1 (AFB1) in die Salmonella fyphimurium mutagenisiteitstoets. 'n Beperkte mate van beskerming is ook verleen teen die oksidatiewe mutageen, waterstofperoksied, sonder metaboliese aktivering. • Verhoogde aktiwiteite van die fase II ensieme, glutatioon S-tranferase alfa en UDP-glukuronidase, wat liggaamsvreemde verbindings metaboliseer. Die kruietees verlaag die oksidasietoestand soos weerspieel word deur 'n toename van gereduseerde glutatioon tot die geoksideerde vorm in die lewer van rotte wat 10 weke hierdie kruietees gedrink he!. Die kruietees het geen toksiese uitwerking op die rotte gehad nie. • Antimutageniese aktiwiteite van subselluiE~re fraksies van die lewer teenoor 2- AAF en AFB1 in die Salmonella toets. Die sitosolfraksie van die rotlewer bied beskerming teen die ge"induseerde mutagenese van beide mutagene, terwyl die mikrosomale fraksie ook die metaboliese aktivering van AFB1 na die aktiewe mutageniese metaboliet verminder. • In vivo modulering van kankerpromosie met behulp van bekende rotlewer en muisvel kankerontwikkelingsmodelle. In die lewermodel het die ongeprosesseerde kruietees beide die ontwikkeling en getal van GSTP+ fokusse onderskeidelik vertraag en verminder. In die geval van die velkankermodel het aanwending van polifenoliese fraksies van die kruietees beskerming gebied teen die ontwikkeling van velkankers by muise. Die aantal en grootte van die tumors het afgeneem terwyl die verskyning daarvan ook vertraag is. • Verskeie meganismes waardeur rooibos- en heuningboslee moonllik kanker kan moduleer word voorgeslel. Verskille in die polifenoliese sameslelling asook hul onderskeie konsenlrasies kan 'n belangrike rol speel in die kankerveranderende effekle van die lees. • Oal gereelde inname van rooibos- en/of heuningboslee moonllik 'n belangrike rol kan speel in die voorkoming van dieel- en omgewings-geYnduseerde kankers.
APA, Harvard, Vancouver, ISO, and other styles
9

Cheng, Ka-wing, and 鄭家榮. "Preventive potential and mechanism of dietary phenolics on the formation of mutagenic heterocyclic amines." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B4284177X.

Full text
Abstract:
The Best PhD Thesis in the Faculties of Dentistry, Engineering, Medicine and Science (University of Hong Kong), Li Ka Shing Prize,2008-2009
published_or_final_version
Biological Sciences
Doctoral
Doctor of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
10

Stapleton, Graham Neil. "A study of the effects of sucralfate in the bile duct litigated pig peptic ulcer model with particular reference to the effects on the physico-chemical properties of gastric mucus and including comparisons with famotidine and misoprostol." Master's thesis, University of Cape Town, 1992. http://hdl.handle.net/11427/25727.

Full text
Abstract:
Sucralfate is a drug that effectively heals duodenal, gastric and oesophageal ulcers. It is not absorbed systemically and it has been shown to act locally by coating the ulcer base. However when it was also shown to prevent stress ulcers and ethanolinduced gastric mucosa! lesions, it seemed likely that it acted in some way to improve the effectiveness of the gastric mucosa! barrier. Some investigators suggested that it did so by stimulating local prostaglandin release. The Slomiany group, on the basis of in vitro work on the effects of Sucralfate on pig gastric mucus, claimed that Sucralfate acted by altering the physico-chemical properties of mucus to increase the viscosity and retard the back diffusion of H+ ions. The work described in this dissertation set out to verify, in vivo, these claimed effects on mucus, using an experimental porcine model of peptic ulceration, the bile duct ligated pig. In addition, the effects of Sucralfate were compared with those of Famotidine and Misoprostol, and changes in mucous prostaglandins, gastric juice pepsin and gastric flora were sought. By way of introduction, the known and postulated actions of Sucralfate, current understanding of gastric mucus physiology and pathogenesis of peptic ulceration, have been reviewed, as have experimental animal models of peptic ulceration, in order to justify using the bile duct ligated pig model.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Therapeutic use of poppies"

1

Mackway-Girardi, AnnMarie. Therapeutic use of interleukin-2. Bethesda, MD: U.S. DHHS, PHS, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Labate, Beatriz Caiuby, and Clancy Cavnar, eds. The Therapeutic Use of Ayahuasca. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-40426-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wosket, Val. The Therapeutic Use of Self. Classic edition. | Milton Park, Abingdon, Oxon ;: Routledge, 2016. http://dx.doi.org/10.4324/9780203772263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

The therapeutic garden. London: Bantam, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tekinay, Ayse B., and Mustafa Ö. Güler. Therapeutic nanomaterials. Hoboken, New Jersey: John Wiley & Sons, Inc., 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Crooke, Stanley T. Therapeutic applications to oligonucleotides. Austin: R.G. Landes Co., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shah, Pragna R. Tantra, its therapeutic aspect. Calcutta: Punthi Pustak, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Liz, Parks, ed. The art of yoga sequencing: A hip opening practice. Denver, Colo: Outskirts Press, Inc., 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rufty, Jodie. The art of yoga sequencing: A hip opening practice. Denver, Colo: Outskirts Press, Inc., 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rufty, Jodie. The art of yoga sequencing: A hip opening practice. Denver, Colo: Outskirts Press, Inc., 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Therapeutic use of poppies"

1

Read, Daniel, James Skinner, Daniel Lock, and Aaron CT Smith. "Therapeutic use exemptions." In WADA, the World Anti-Doping Agency, 102–23. First. | Milton Park, Abingdon, Oxon ; New York NY : Routledge, 2021. | Series: Routledge research in sport and corruption: Routledge, 2021. http://dx.doi.org/10.4324/9781003084297-6-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lanzotti, Virginia. "Diterpenes for Therapeutic Use." In Natural Products, 3173–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-22144-6_192.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wiltenburg, Victor Distefano, Dianne da Rocha Prado, and Fúlvio Rieli Mendes. "Therapeutic Use of Hallucinogens." In Drugs and Human Behavior, 479–510. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62855-0_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Aranki, S. F., F. Mannting, S. K. Shernan, N. C. Cummings, S. P. Sears, and L. H. Cohn. "Transmyocardial Laser Use for Endstage Coronary Artery Disease." In Therapeutic Angiogenesis, 163–73. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-03776-8_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chugh, Atul R., Samir N. Patel, Venkataraman Rajaram, Rachel Neems, Matt Feinstein, Marshall Goldin, and Steven B. Feinstein. "The Clinical Use of Noninvasive Modalities in the Assessment of Atherosclerosis." In Therapeutic Lipidology, 389–408. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-533-6_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Woods, David. "The therapeutic use of self." In Clinical Supervision and Mentorship in Nursing, 37–49. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4899-7228-6_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Oh, So Won, and Dong Soo Lee. "Therapeutic/Theranostic Use of Radionanomedicine." In Radionanomedicine, 431–42. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67720-0_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Martin, Peggy. "The therapeutic use of self." In Psychiatric Nursing, 38–48. London: Macmillan Education UK, 1987. http://dx.doi.org/10.1007/978-1-349-09408-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bukowski, Ronald M. "Therapeutic Use of Recombinant Proteins." In Biopharmaceutical Drug Design and Development, 393–427. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-705-5_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Greer, George R., and Requa Tolbert. "The Therapeutic Use of MDMA." In Topics in the Neurosciences, 21–35. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-1485-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Therapeutic use of poppies"

1

Fikar, Peter, Florian Güldenpfennig, and Roman Ganhör. "The Use(fulness) of Therapeutic Toys." In DIS '18: Designing Interactive Systems Conference 2018. New York, NY, USA: ACM, 2018. http://dx.doi.org/10.1145/3196709.3196721.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dahl, Elizabeth. "Towards the use of HIFU, in Conjunction with Surgery, in the Treatment of Malignant Brain Tumors." In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205469.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

McLaughlan, James. "The Design And Implementation Of A Passive Cavitation Detection System For Use With Ex Vivo Tissue." In THERAPEUTIC ULTRASOUND: 5th International Symposium on Therapeutic Ultrasound. AIP, 2006. http://dx.doi.org/10.1063/1.2205493.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bera, Jean-Christophe, Bruno Gilles, Izella Saletes, Claude Inserra, and Hiva Shamsborhan. "Numerical study of cavitation threshold by use of bifrequency excitation." In 11TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2012. http://dx.doi.org/10.1063/1.4757304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Payne, A., A. Blankespoor, N. Todd, U. Vyas, D. Christensen, D. Parker, R. Roemer, and Emad S. Ebbini. "Optimization of HIFU Treatments for Use in Model Predictive Control." In 8TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2009. http://dx.doi.org/10.1063/1.3131406.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kaneko, Yukio. "The Design Of Microbubbles Specialized For Therapeutic Or Diagnostic Use." In 4TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2005. http://dx.doi.org/10.1063/1.1901643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wong, Serena H., Ronald D. Watkins, Mario Kupnik, Kim Butts Pauly, B. T. Khuri-Yakub, and Emad S. Ebbini. "Progress in Development of HIFU CMUTs for use under MR-guidance." In 8TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2009. http://dx.doi.org/10.1063/1.3131441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Amato, Federica, Marianna Di Gregorio, Clara Monaco, Monica Sebillo, Genoveffa Tortora, and Giuliana Vitiello. "The Therapeutic Use of Humanoid Robots for Behavioral Disorders." In AVI '20: International Conference on Advanced Visual Interfaces. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3399715.3399960.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Payne, Allison H., Dennis L. Parker, Jeff Moellmer, Robert B. Roemer, and Sarah Clifford. "Characterization of an Isolated Kidney’s Vasculature for Use in Bio-Thermal Modeling." In 6TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2007. http://dx.doi.org/10.1063/1.2744297.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

McDannold, Nathan, Natalia Vykhodtseva, and Kullervo Hynynen. "Use of Ultrasound Pulses Combined with Definity for Targeted Blood-Brain Barrier Disruption." In 6TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2007. http://dx.doi.org/10.1063/1.2744328.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Therapeutic use of poppies"

1

Evans, Holly. The Use of Filariae as a Therapeutic Agent for Hypersensitivity Diseases. Fort Belvoir, VA: Defense Technical Information Center, November 2014. http://dx.doi.org/10.21236/ad1012825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lillo, Antonietta. Harnessing in vitro evolution to discover antibodies for therapeutic and diagnostic use. Office of Scientific and Technical Information (OSTI), March 2021. http://dx.doi.org/10.2172/1773320.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Baldi, Emilio. The Use of Extremely Low Frequencies (ELF) in Pulsed Form (PELF) for Therapeutic Use: A Pilot Study. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada409410.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Templeton, Charles B., Mark A. Poli, and Rikki Solow. Prophylactic and Therapeutic Use of an Anti-Brevetoxin (PbTx-2) Antibody in Conscious Rats. Fort Belvoir, VA: Defense Technical Information Center, May 1988. http://dx.doi.org/10.21236/ada210932.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

O'Keefe, Denise S., and Warren D. Heston. Characterization of Prostate-Specific Membrane Antigen (PSMA) for Use in Therapeutic and Diagnostic Strategies Against Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2002. http://dx.doi.org/10.21236/ada407353.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Klimas, Nancy G., and Mary A. Fletcher. The Use of Comprehensive Molecular Profiling With Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Fort Belvoir, VA: Defense Technical Information Center, July 2010. http://dx.doi.org/10.21236/ada529400.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Klimas, Nancy G., and Mary A. Fletcher. The Use of Comprehensive Molecular Profiling with Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Fort Belvoir, VA: Defense Technical Information Center, July 2012. http://dx.doi.org/10.21236/ada568442.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Klimas, Nancy G., and Mary A. Fletcher. The Use of Comprehensive Molecular Profiling with Network and Control Theory to Better Understand GWI and Model Therapeutic Strategies. Fort Belvoir, VA: Defense Technical Information Center, July 2011. http://dx.doi.org/10.21236/ada554188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lelievre, Sophie A. The Use of a Human Breast Tumor Progression Series and a 3-D Culture Model to Determine if Nuclear Structure Could Provide a Molecular and Therapeutic Marker. Fort Belvoir, VA: Defense Technical Information Center, October 1998. http://dx.doi.org/10.21236/adb248428.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wiley, Jenny L., Camille K. Gourdet, and Brian F. Thomas. Cannabidiol: Science, Marketing, and Legal Perspectives. RTI Press, April 2020. http://dx.doi.org/10.3768/rtipress.2020.op.0065.2004.

Full text
Abstract:
Recent loosening of legal restrictions on cannabis and its chemical constituents, including phytocannabinoids such as Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), has led to rapid proliferation and wide availability of products containing CBD. Although using pure CBD does not result in THC-like intoxication, it is not risk-free. In this review, we examine CBD from scientific, marketing, and regulatory perspectives. Specifically, we evaluate the evidence used to support statements concerning CBD’s real and putative medical effects and discuss misleading information that has been used in marketing approaches. Also, we explore the current legal landscape surrounding CBD. We conclude that further research is necessary to clarify legitimate therapeutic effects of CBD. Federal regulation is also necessary to assure quality, safety, and efficacy of CBD products. Until new regulations are enacted to ensure purity and label accuracy, consumers should balance any perceived benefits of CBD use against potential risks associated with using products of unknown quality.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography